BCT score predicts chemotherapy benefit in Asian patients with hormone receptor-positive, HER2-negative, lymph node-negative breast cancer

The Breast Cancer Test (BCT) score has been validated for its ability to predict the risk of distant metastasis in hormone receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative early breast cancer. This study aimed to examine the value of the BCT score for predicting the benefi...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:PLoS One
Hlavní autoři: Kwon, Mi Jeong, Lee, Sae Byul, Han, Jinil, Lee, Jeong Eon, Lee, Jong Won, Gong, Gyungyub, Beitsch, Peter D., Nam, Seok Jin, Ahn, Sei Hyun, Nam, Byung-Ho, Shin, Young Kee
Médium: Artigo
Jazyk:Inglês
Vydáno: Public Library of Science 2018
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6248959/
https://ncbi.nlm.nih.gov/pubmed/30462685
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0207155
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky